Investors
Global Investors
At KIC Ventures, we’re transforming the future of spine surgery through strategic investments and physician-led innovation. By maintaining majority ownership in our portfolio companies, we have the control and agility needed to drive advancements that address real clinical needs.Physician-Led Leadership
Long-Term Strategic Investments
We focus on sustainable growth by acquiring breakthrough technologies like AxioMed’s viscoelastic discs and NanoFuse Biologics for their long-term potential. With AxioMed’s targeted launch next year and key milestones ahead, including international expansion, we are positioned to accelerate growth and our valuation.
Collaboration Plus Data
True success stems from collaboration among our spine colleagues, esteemed chief medical officers, and dedicated engineers, working together to measure data and produce peer-reviewed research. This approach aligns us with the actual needs of surgeons and patients, ensuring we deliver impactful solutions.
Proven Commercialization
NANISX, our LESS™ Exposure Advanced Spine Technologies (LEAST™) platform, is dedicated to driving the global transformation of outpatient Interventional Spine Surgery (ISSU™)—drawing inspiration from the breakthroughs pioneered in interventional cardiology. Since 2021, NANISX has delivered consistent growth and profitability, achieving positive EBITDA while proving our ability to translate innovation into real-world clinical and financial success.
Physician-Led Leadership
With medical experience dating back to 1992 and 20+ years of clinical expertise as an orthopedic spine surgeon, our physician-founder and CEO brings a deep understanding of the needs of surgeons and patients, giving us a unique advantage in shaping the future of outpatient spine surgery.
We have always believed in building for the long-term
-Dr Kingsley R Chin MBA CEO
The Problem
400 million people suffer from degenerative disc disease. The standard solution? Spinal fusion. Half a million fusions are performed each year in the U.S. alone — costly procedures that eliminate motion and accelerate adjacent segment degeneration. There has to be a better way.
The Market
A $15B+ global spine market. Procedures are shifting from hospital inpatient settings to ambulatory surgery centers. More than 4,500 interventional pain physicians are now being trained to perform interventional spine surgery in the ASC setting. The next growth wave favors outpatient, motion-preserving solutions.
Investment Thesis
We build value through a hands-on partnership over a 5–10 year horizon, acquiring, incubating, and scaling physician-led technology companies. Our focus is on engineering durable businesses that deliver real clinical impact, enable repeatable adoption, and generate sustained, long-term investor growth